Metabolomics

Papers
(The TQCC of Metabolomics is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
New software tools, databases, and resources in metabolomics: updates from 2020129
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome64
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis46
Salivary metabolomics for the diagnosis of periodontal diseases: a systematic review with methodological quality assessment35
Metabolomics on the study of marine organisms32
Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore Longitudinal Study of Aging30
Forensic NMR metabolomics: one more arrow in the quiver27
Gas chromatography/mass spectrometry-based metabolite profiling of coffee beans obtained from different altitudes and origins with various postharvest processing26
Identification of markers of sensory quality in ground coffee: an untargeted metabolomics approach26
The remodel of the “central dogma”: a metabolomics interaction perspective26
Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches23
Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction—liquid chromatography—high-resolution mass spectrometry22
Prenatal exposure to poly-/per-fluoroalkyl substances is associated with alteration of lipid profiles in cord-blood20
A non-targeted LC–MS metabolic profiling of pregnancy: longitudinal evidence from healthy and pre-eclamptic pregnancies20
Serum metabolomic patterns in young patients with ischemic stroke: a case study19
Comparison of dried blood spot and plasma sampling for untargeted metabolomics19
Metabolomic and elemental profiling of human tissue in kidney cancer18
The verification of the reliability of a triglyceride–glucose index and its availability as an advanced tool18
Metabolic signatures of osteoarthritis in urine using liquid chromatography‐high resolution tandem mass spectrometry17
Sex and race differences of cerebrospinal fluid metabolites in healthy individuals17
Metabolomics analysis reveals altered metabolites in lean compared with obese adolescents and additional metabolic shifts associated with hyperinsulinaemia and insulin resistance in obese adolescents:17
Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis16
Integrating in vitro metabolomics with a 96-well high-throughput screening platform16
Metabolomics by UHPLC-HRMS reveals the impact of heat stress on pathogen-elicited immunity in maize16
Untargeted metabolomics in primary murine bone marrow stromal cells reveals distinct profile throughout osteoblast differentiation16
Metabolites involved in purine degradation, insulin resistance, and fatty acid oxidation are associated with prediction of Gestational diabetes in plasma16
Comparative metabolic profiles of total and partial body radiation exposure in mice using an untargeted metabolomics approach15
Applying NMR compound identification using NMRfilter to match predicted to experimental data15
Spatially resolved metabolomic characterization of muscle invasive bladder cancer by mass spectrometry imaging14
Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS14
Chemotaxonomic profiling of fungal endophytes of Solanum mauritianum (alien weed) using gas chromatography high resolution time-of-flight mass spectrometry (GC-HRTOF-MS)14
Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function14
Workshop report: Toward the development of a human whole stool reference material for metabolomic and metagenomic gut microbiome measurements14
One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation14
0.046710968017578